Idexx Laboratories Inc /De financial data

Symbol
IDXX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
One Idexx Drive, Westbrook, ME
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 141 % +5.02%
Quick Ratio 37.2 % -7.82%
Debt-to-equity 111 % -28.5%
Return On Assets 26.5 % -5.8%
Operating Margin 29 % -3.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 81.3M shares -2.12%
Common Stock, Shares, Outstanding 81.6M shares -1.72%
Entity Public Float 40.1B USD -3.01%
Common Stock, Value, Issued 10.8M USD +0.31%
Weighted Average Number of Shares Outstanding, Basic 82.5M shares -0.72%
Weighted Average Number of Shares Outstanding, Diluted 83.2M shares -0.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.9B USD +6.46%
Cost of Revenue 1.51B USD +4.95%
Research and Development Expense 220M USD +15.1%
Selling and Marketing Expense 589M USD +3.96%
General and Administrative Expense 442M USD +31.7%
Operating Income (Loss) 1.13B USD +2.85%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.11B USD +4.59%
Income Tax Expense (Benefit) 222M USD +2.7%
Net Income (Loss) Attributable to Parent 888M USD +5.07%
Earnings Per Share, Basic 10.8 USD/shares +5.9%
Earnings Per Share, Diluted 10.7 USD/shares +6.06%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 288M USD -36.5%
Accounts Receivable, after Allowance for Credit Loss, Current 474M USD +3.53%
Inventory, Net 382M USD +0.42%
Other Assets, Current 256M USD +25.8%
Assets, Current 1.4B USD -6.38%
Deferred Income Tax Assets, Net 126M USD +17%
Property, Plant and Equipment, Net 713M USD +1.56%
Operating Lease, Right-of-Use Asset 116M USD +0.55%
Intangible Assets, Net (Excluding Goodwill) 112M USD +32.2%
Goodwill 405M USD +10.7%
Other Assets, Noncurrent 548M USD +10.3%
Assets 3.29B USD +1.03%
Accounts Payable, Current 114M USD +3.23%
Employee-related Liabilities, Current 175M USD +0.12%
Accrued Liabilities, Current 502M USD +4.89%
Contract with Customer, Liability, Current 33.8M USD -9.13%
Liabilities, Current 1.07B USD +12.2%
Contract with Customer, Liability, Noncurrent 26.9M USD -5.59%
Accrued Income Taxes, Noncurrent 20.9M USD -47.3%
Deferred Income Tax Liabilities, Net 11.3M USD +56.4%
Operating Lease, Liability, Noncurrent 97.8M USD -1.84%
Other Liabilities, Noncurrent 44.3M USD -32.3%
Liabilities 1.7B USD -4.35%
Accumulated Other Comprehensive Income (Loss), Net of Tax -93.6M USD -31.5%
Retained Earnings (Accumulated Deficit) 5.33B USD +20%
Stockholders' Equity Attributable to Parent 1.6B USD +7.46%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.48B USD +144%
Liabilities and Equity 3.29B USD +1.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 199M USD +7.98%
Net Cash Provided by (Used in) Financing Activities -144M USD +1.37%
Net Cash Provided by (Used in) Investing Activities -107M USD -171%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 108M shares +0.31%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -56.5M USD -4692%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 288M USD -36.5%
Deferred Tax Assets, Valuation Allowance 31.9M USD -8.24%
Deferred Tax Assets, Gross 278M USD +13%
Operating Lease, Liability 119M USD -0.08%
Payments to Acquire Property, Plant, and Equipment 30.3M USD -23.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 865M USD +1.62%
Lessee, Operating Lease, Liability, to be Paid 140M USD -0.37%
Property, Plant and Equipment, Gross 1.55B USD +4.11%
Operating Lease, Liability, Current 21.5M USD +8.77%
Lessee, Operating Lease, Liability, to be Paid, Year Two 26.5M USD +13%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.4M USD +8.82%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -2.57M USD +31.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.7M USD -2.01%
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.1M USD +0.45%
Deferred Tax Assets, Operating Loss Carryforwards 6.65M USD -26.2%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 18.1M USD -18.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 15.1M USD -6.38%
Operating Lease, Payments 7.16M USD -7.97%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 29.9M USD +5.55%
Deferred Tax Assets, Net of Valuation Allowance 247M USD +16.5%
Share-based Payment Arrangement, Expense 60.3M USD +0.93%
Interest Expense 36.4M USD -20.9%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%